Nanomaterials for acute myeloid leukemia therapy: Current progress and future perspectives

Nanomaterials for acute myeloid leukemia therapy: Current progress and future perspectives

Abstract Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by poor prognosis, high relapse rates, and resistance to conventional chemotherapy. The limitations of standard treatments, including systemic toxicity and non‐specific drug distribution, highlight the...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiarui Zhao, Jiaqi Cui, Lixuan Wang, Xinyi Shi, Jiayan Ding, Muhammad Farhan Sohail, Irshad Hussain, Qihui Liu, Fangfang Chen
Format: Article
Language:English
Published: Wiley-VCH 2025-05-01
Series:Interdisciplinary Medicine
Subjects:
anti‐drug resistance
nanoparticles (NPs)
targeted drug delivery
therapeutic strategy
Online Access:https://doi.org/10.1002/INMD.20240131
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/INMD.20240131

Similar Items